Regenicin, Inc. reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported net loss was USD 0.277514 million compared to USD 0.154125 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% |
|
-.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 15.35K | |
+16.45% | 122B | |
+21.96% | 116B | |
+23.87% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- RGIN Stock
- News Regenicin, Inc.
- Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022